LUCD – lucid diagnostics inc. (US:NASDAQ)
Stock Stats
News
Lucid Diagnostics Launches "Embrace the Future" Campaign Showcasing EsoCheck's Groundbreaking Collect+Protect Esophageal Cell Collection Technology
Lucid Diagnostics Inc. (NASDAQ: LUCD) was given a new $2.00 price target on by analysts at BTIG Research.
Lucid Diagnostics Inc. (NASDAQ: LUCD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $2.00 price target on the stock.
Lucid Diagnostics Inc. (NASDAQ: LUCD) had its price target raised by analysts at Needham & Company LLC from $2.50 to $3.00. They now have a "buy" rating on the stock.
Lucid Diagnostics Inc. (LUCD) Q4 2024 Earnings Call Transcript [Seeking Alpha]
Form 8-K Lucid Diagnostics Inc. For: Mar 24
Form 10-K Lucid Diagnostics Inc. For: Dec 31
Form 8-K Lucid Diagnostics Inc. For: Mar 05
Form 424B5 Lucid Diagnostics Inc.
Form 8-K Lucid Diagnostics Inc. For: Mar 04
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.